| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Jones DE | |
| Prince MI | |||
| P2860 | cites work | Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis | Q77225890 |
| Fatigue in primary biliary cirrhosis | Q77586211 | ||
| Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosis | Q77716502 | ||
| Breakdown of tolerance to pyruvate dehydrogenase complex in experimental autoimmune cholangitis: a mouse model of primary biliary cirrhosis | Q77933483 | ||
| Asymptomatic primary biliary cirrhosis. A progress report on long-term follow-up and natural history | Q93573634 | ||
| Cancer risk in primary biliary cirrhosis: a population-based study from Sweden | Q95780366 | ||
| Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis | Q24542418 | ||
| Mitochondrial antibodies in primary biliary cirrhosis. I. Localization of the antigen to mitochondrial membranes | Q24679440 | ||
| A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 | ||
| Hepatocellular and biliary expression of HLA antigens in primary biliary cirrhosis before and after ursodeoxycholic acid therapy | Q28332915 | ||
| Treatment of primary biliary cirrhosis with low-dose weekly methotrexate | Q33384106 | ||
| Primary biliary cirrhosis once rare, now common in the United Kingdom? | Q33869156 | ||
| Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis? | Q34190802 | ||
| SEROLOGICAL TESTS IN DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS | Q34259351 | ||
| Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis | Q34377943 | ||
| Characterisation of patients with a complete biochemical response to ursodeoxycholic acid | Q34408204 | ||
| Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes | Q34445524 | ||
| Breast cancer in women with primary biliary cirrhosis | Q34491081 | ||
| Serum bilirubin: a prognostic factor in primary biliary cirrhosis | Q34494336 | ||
| The association between primary biliary cirrhosis and coeliac disease: a study of relative prevalences | Q35348722 | ||
| Autoantibodies against subunits of pyruvate dehydrogenase and citrate synthase in a case of paediatric biliary cirrhosis | Q35350953 | ||
| Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis | Q36465636 | ||
| Ursodeoxycholic acid therapy for primary biliary cirrhosis. A 10-year British single-centre population-based audit of efficacy and survival | Q36612947 | ||
| Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England | Q39452020 | ||
| Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial | Q39533520 | ||
| Primary biliary cirrhosis: Dutch application of the Mayo Model before and after orthotopic liver transplantation | Q39547588 | ||
| The pruritus of cholestasis: potential pathogenic and therapeutic implications of opioids | Q40513479 | ||
| Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis | Q40883127 | ||
| The clinical expression of primary biliary cirrhosis | Q40904955 | ||
| The geoepidemiology of primary biliary cirrhosis | Q40904961 | ||
| A controlled trial of naloxone infusions for the pruritus of chronic cholestasis | Q41142015 | ||
| Accurate prediction of death by serial determination of galactose elimination capacity in primary biliary cirrhosis: a comparison with the Mayo model | Q41144258 | ||
| Natural history of early primary biliary cirrhosis | Q41234807 | ||
| A prospective clinical trial of D-penicillamine in the treatment of primary biliary cirrhosis | Q42225446 | ||
| Ursodeoxycholic acid treatment in patients with primary biliary cirrhosis. A Swedish multicentre, double-blind, randomized controlled study | Q42551010 | ||
| A prospective trial of colchicine for primary biliary cirrhosis | Q42659809 | ||
| Double blind controlled trial of d-penicillamine in patients with primary biliary cirrhosis | Q43214926 | ||
| Extramural cross-validation of the Mayo primary biliary cirrhosis survival model establishes its generalizability | Q43475774 | ||
| Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: what is the risk? | Q43676662 | ||
| Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial | Q43766090 | ||
| The prevalence and clinical spectrum of primary biliary cirrhosis in a defined population. | Q43973385 | ||
| Cross-reactivity of anti-Mycobacterium gordonae antibodies with the major mitochondrial autoantigens in primary biliary cirrhosis | Q44367880 | ||
| The demography of primary biliary cirrhosis in Ontario, Canada | Q44439436 | ||
| Use of prognostic models for assessment of value of liver transplantation in primary biliary cirrhosis | Q44538516 | ||
| Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis. | Q44573504 | ||
| The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis | Q45024371 | ||
| Characterization of antimitochondrial antibodies in health adults | Q46110088 | ||
| Prognosis in primary biliary cirrhosis: model for decision making | Q46316848 | ||
| A study of antimitochondrial antibodies in a random population in Estonia. | Q46833277 | ||
| Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders | Q47992000 | ||
| Quality of life before and after liver transplantation for cholestatic liver disease | Q48773263 | ||
| Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis? | Q49100848 | ||
| The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis | Q49110706 | ||
| A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis | Q51586165 | ||
| Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment. | Q51650453 | ||
| Serial determination of type III procollagen amino propeptide serum levels in patients with histologically progressive and non-progressive primary biliary cirrhosis | Q52428985 | ||
| Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients. | Q53441958 | ||
| M2 mitochondrial antibodies and urinary rough mutant bacteria in patients with primary biliary cirrhosis and in patients with recurrent bacteriuria. | Q54661589 | ||
| Familial primary biliary cirrhosis reassessed: a geographically-based population study | Q61633902 | ||
| Tumour necrosis factor-a promoter polymorphisms in primary biliary cirrhosis | Q61633903 | ||
| Oral naltrexone treatment for cholestatic pruritus: A double-blind, placebo-controlled study | Q61854318 | ||
| Presentation and course of asymptomatic primary biliary cirrhosis | Q67583636 | ||
| A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results | Q67590480 | ||
| Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis | Q67926514 | ||
| Evaluation of colchicine therapy in primary biliary cirrhosis | Q68139571 | ||
| Serum hyaluronate in primary biliary cirrhosis--a biochemical marker for progressive liver damage | Q68257554 | ||
| Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study | Q68781360 | ||
| Primary biliary cirrhosis | Q68930413 | ||
| The Presentation and Diagnosis of 100 Patients with Primary Biliary Cirrhosis | Q69302463 | ||
| Prognosis after liver transplantation for primary biliary cirrhosis | Q69538672 | ||
| The N-terminal propeptide of collagen type III in serum as a prognostic indicator in primary biliary cirrhosis | Q69550249 | ||
| Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens | Q69917880 | ||
| Primary biliary cirrhosis: clinical features and outcome, with special reference to asymptomatic disease | Q69971289 | ||
| Preliminary study of indocyanine green clearance in primary biliary cirrhosis | Q70121809 | ||
| Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial | Q70542319 | ||
| Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid therapy | Q70670255 | ||
| Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis | Q71035932 | ||
| Primary biliary cirrhosis: an epidemiological study | Q71354203 | ||
| Pruritus associated with cholestatic liver disease | Q71634182 | ||
| A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group | Q71748735 | ||
| Fatigue associated with chronic liver disease: A riddle wrapped in a mystery inside an enigma | Q71818804 | ||
| A two year controlled trial examining the effectiveness of ursodeoxycholic acid in primary biliary cirrhosis | Q71995039 | ||
| Primary biliary cirrhosis: prediction of short-term survival based on repeated patient visits | Q72036541 | ||
| Autoimmune cholangitis: a variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases | Q72313586 | ||
| Primary biliary cirrhosis | Q72331434 | ||
| Prediction of prognosis of primary biliary cirrhosis in Japan | Q72336290 | ||
| Ursodeoxycholic acid in the treatment of primary biliary cirrhosis | Q72401649 | ||
| Primary biliary cirrhosis--a revised clinical spectrum | Q72471842 | ||
| Antimitochondrial antibody-negative primary biliary cirrhosis | Q72524305 | ||
| Malignancy in primary biliary cirrhosis. High incidence of breast cancer in affected women | Q72581294 | ||
| Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model. PBC1 and PBC2 trial groups | Q72638625 | ||
| Primary biliary cirrhosis: survival of a large cohort of symptomatic and asymptomatic patients followed for 24 years | Q72727069 | ||
| Improvement in cholestasis-associated fatigue with a serotonin receptor agonist using a novel rat model of fatigue assessment | Q73043056 | ||
| Sustained biochemical and histologic remission of primary biliary cirrhosis in response to medical treatment | Q73316077 | ||
| Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis | Q73319901 | ||
| Transplantation for primary biliary cirrhosis | Q73384255 | ||
| Antimitochondrial antibody profiles in primary biliary cirrhosis distinguish at early stages between a benign and a progressive course: a prospective study on 200 patients followed for 10 years | Q73569242 | ||
| Autoimmune conditions associated with primary biliary cirrhosis: response to ursodeoxycholic acid therapy | Q74730516 | ||
| Chronic cholestasis in rats induces anhedonia and a loss of social interest | Q74764234 | ||
| Primary biliary cirrhosis | Q75610531 | ||
| Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy | Q77058192 | ||
| Detection of retroviral antibodies in primary biliary cirrhosis | Q77206771 | ||
| P433 | issue | 894 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | primary biliary cholangitis | Q1072420 |
| P304 | page(s) | 199-206 | |
| P577 | publication date | 2000-04-01 | |
| P1433 | published in | Postgraduate Medical Journal | Q7234294 |
| P1476 | title | Primary biliary cirrhosis: new perspectives in diagnosis and treatment | |
| P478 | volume | 76 |
| Q79770376 | Assessing quality of life in primary biliary cirrhosis |
| Q36119487 | Extrahepatic manifestations of cholestatic liver diseases: pathogenesis and therapy |
| Q35596429 | Fatigue and primary biliary cirrhosis: association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels. |
| Q34114608 | Fatigue in primary biliary cirrhosis |
| Q35760389 | Four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort |
| Q92003565 | From pruritus to CREST syndrome in a middle aged woman |
| Q43725734 | Impact of primary biliary cirrhosis on perceived quality of life: the UK-PBC national study |
| Q85614111 | Membranous nephropathy associated with primary biliary cirrhosis and acute meningitis |
| Q73735616 | Pain as a complication of use of opiate antagonists for symptom control in cholestasis |
| Q34653850 | Pathogenesis of primary biliary cirrhosis |
| Q34328076 | Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study. |
| Q84230884 | Primary biliary cirrhosis |
| Q26853145 | Primary biliary cirrhosis and liver transplantation |
| Q50900931 | The role of psychological factors in the fatigue of primary biliary cirrhosis. |
| Q35063685 | Treatment of pruritus associated with systemic disorders in the elderly: a review of the role of new therapies |
Search more.